// App-Quantinova.ai

901-4 : CHARACTERIZATION OF THE MYOCARDIAL INFARCTION ENDPOINTS, IMPACT OF EVENT ADJUDICATION, AND TICAGRELOR EFFECTS IN THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL

Researchers

Presenter

  • Kenneth W. Mahaffev

Principal Investigators

  • Daniel Wojdyla

  • Stefan James

  • Hugo Katus

  • Steen Husted

  • Philippe Steg

  • Christopher Cannon

  • Richard Becker

  • Claes Held

  • Nardev Khurmi

  • Debra Montgomery

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Ticagrelor

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim